PRECEDEX 4 MCG — DIN 02437147
DEXMEDETOMIDINE (DEXMEDETOMIDINE HYDROCHLORIDE) : 4 MCG · PFIZER CANADA ULC · SOLUTION · wholesale supply in Canada
Health Canada status: MARKETED
What is PRECEDEX?
PRECEDEX 4 MCG contains DEXMEDETOMIDINE (DEXMEDETOMIDINE HYDROCHLORIDE) : 4 MCG. It is listed in the Health Canada Drug Product Database under DIN 02437147, held by PFIZER CANADA ULC, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 04-Mar-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is PRECEDEX used for?
Sedation of initially intubated/mechanically ventilated adults in ICU (usually <24h). Conscious sedation in non-intubated adults for Monitored Anesthesia Care and Awake Fiberoptic Intubation.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Dexmedetomidine cost around the world?
Dexmedetomidine is listed on 5 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Bahrain publishes a retail (max); Greece publishes a producer price (ex-factory); Saudi Arabia publishes a public. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Saudi Arabia | public | 8 | 13 | SAR███.██ |
| Greece | producer price (ex-factory) | 8 | 8 | EUR███.██ |
| United Kingdom | hospital | 7 | 7 | GBP███.██ |
| South Africa | single exit price | 3 | 3 | ZAR███.██ |
| Bahrain | retail (max) | 1 | 1 | BHD███.██ |
32 pack listings across 27 brand entries and 5 price bases, refreshed 03 Sep 2026. Ranges span every Dexmedetomidine pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Dexmedetomidine in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
10 holders have a Canadian DIN containing Dexmedetomidine, across 16 DINs, of which 9 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| JUNO PHARMACEUTICALS CORP. | 3 | 3 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP, DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | Sourceable in Canada |
| HIKMA CANADA LIMITED | 2 | 1 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION USP, DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | Sourceable in Canada |
| PFIZER CANADA ULC | 2 | 1 | PRECEDEX | Sourceable in Canada |
| ACCORD HEALTHCARE INC | 1 | 1 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | Sourceable in Canada |
| AURO PHARMA INC | 1 | 1 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | Sourceable in Canada |
| BAXTER CORPORATION | 1 | 1 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP | Sourceable in Canada |
| EUGIA PHARMA INC. | 1 | 1 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | Sourceable in Canada |
| OMEGA LABORATORIES LIMITED | 3 | 0 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP, DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | No marketed DIN |
| FRESENIUS KABI CANADA LTD | 1 | 0 | DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | No marketed DIN |
| SANDOZ CANADA INCORPORATED | 1 | 0 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 4 MCG |
|---|---|
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Pack configuration (monograph) | 100 mcg/mL: 2 mL clear glass vials. 4 mcg/mL: 20 mL, 50 mL, and 100 mL glass vials. Single use only. |
| Storage | Reconstituted solution (from concentrate) is stable for 25 hours at room temperature (15 - 30°C). |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Dexmedetomidine |
|---|---|
| ATC code | N05CM18 |
| AHFS class | 28:24.92 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02437147 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2437147 |
| Brand name | PRECEDEX |
| Generic / active ingredient | DEXMEDETOMIDINE (DEXMEDETOMIDINE HYDROCHLORIDE) : 4 MCG |
| Market authorization holder | PFIZER CANADA ULC |
| Health Canada schedule | Prescription |
| ATC code | N05CM18 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N05CM |
| Current status | MARKETED |
| Status date | 04-Mar-2019 |
| Original market date | 2016-05-09 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
ICU: Loading 1.0 mcg/kg over 10 min, maintenance 0.2-0.7 mcg/kg/hr. Conscious Sedation: Loading 0.5-1.0 mcg/kg over 10 min, maintenance 0.2-1.0 mcg/kg/hr. Administer via controlled infusion device.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to dexmedetomidine hydrochloride or any ingredient in the formulation or component of the container.
Warnings and precautions
Risk of hypotension, bradycardia, sinus arrest, and transient hypertension. Increased mortality risk in ICU patients ≤65 years (SPICE III study). Risk of hyperthermia and polyuria.
Is Dexmedetomidine in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Anticipated — reported by HIKMA CANADA LIMITED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
9 of 16 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | 100 MCG | SOLUTION | EUGIA PHARMA INC. | MARKETED | 02528886 |
| DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | 100 MCG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED | 02477327 |
| DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | 100 MCG | SOLUTION | AURO PHARMA INC | MARKETED | 02464381 |
| DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP | 100 MCG | SOLUTION | JUNO PHARMACEUTICALS CORP. | MARKETED | 02467976 |
| DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP | 100 MCG | SOLUTION | BAXTER CORPORATION | MARKETED | 02513978 |
| DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | 4 MCG | SOLUTION | HIKMA CANADA LIMITED | MARKETED | 02537109 |
| DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | 200 MCG / 50 ML | SOLUTION | JUNO PHARMACEUTICALS CORP. | MARKETED | 02487365 |
| DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | 400 MCG / 100 ML | SOLUTION | JUNO PHARMACEUTICALS CORP. | MARKETED | 02487373 |
| DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | 100 MCG | SOLUTION | SANDOZ CANADA INCORPORATED | CANCELLED PRE MARKET | 02493314 |
| DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION USP | 100 MCG | SOLUTION | HIKMA CANADA LIMITED | APPROVED | 02537095 |
2 · Same class — other molecules in ATC N05CM
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Dexmedetomidine | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION · DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION USP · DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP · DEXMEDETOMIDINE HYDROCHLORIDE INJECTION · +1 more | 16 | 9 | Yes |
| Scopolamine | SCOPOLAMINE HYDROBROMIDE INJECTION | 2 | 2 | Yes |
| Valerianae Radix | ARTRYL CAP 200 MG · EFFIDOSE VALERIANE LIQ 1916MG/10ML AMP · ETHICAL HERBALS SLEEP AID · FACILITE LE SOMMEIL - CAP 270MG · +6 more | 10 | 0 | Not in Canada |
| Ethchlorvynol | PLACIDYL CAP 200MG · PLACIDYL CAP 500MG · PLACIDYL CAP 750MG | 3 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC N05C
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| N05CF | Eszopiclone · Zaleplon · Zolpidem · Zopiclone | 125 | 57 |
| N05CD | Estazolam · Flurazepam · Midazolam · Nitrazepam · Temazepam · +1 more | 108 | 21 |
| N05CC | Chloral Hydrate · Paraldehyde | 9 | 1 |
| N05CJ | Daridorexant · Suvorexant | 6 | 1 |
| N05CA | Amobarbital · Barbiturates, Plain · Pentobarbital · Secobarbital | 14 | 0 |
| N05CB | Combinations Of Barbiturates | 2 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is PRECEDEX called?
The same molecule, Dexmedetomidine, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Dormidex | Latin | Saudi Arabia |
| SOPORIDEX | Latin | Saudi Arabia |
| Naplax | Latin | Saudi Arabia |
| Demexa | Latin | Saudi Arabia |
| Dexdor | Latin | Saudi Arabia |
| DEXISUN | Latin | South Africa |
| Dexmedetomidine PSI | Latin | Saudi Arabia |
| Eccladex | Latin | South Africa |
| Precia | Latin | South Africa |
| Proxida | Latin | Saudi Arabia |
| SEDALERT | Latin | Bahrain |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.